DMARD stands for Disease-Modifying Anti-Rheumatic Drug. Unlike painkillers, DMARDs damp down the overactive immune response driving conditions like rheumatoid, psoriatic and juvenile arthritis, which slows joint damage over months. Conventional DMARDs include methotrexate, sulfasalazine, hydroxychloroquine and leflunomide — nearly always started by an UK healthcare rheumatologist, then monitored with regular blood tests. They typically take 6–12 weeks to work. If they don't control disease activity, the team may add or switch to a biologic or targeted synthetic DMARD.
What is dmard?
DMARD: DMARDs are drugs that slow the underlying disease process in inflammatory arthritis (RA, PsA, JIA). Conventional DMARDs include methotrexate, sulfasalazine, hydroxychloroquine and leflunomide. Starting a DMARD within 3 months of RA symptoms significantly reduces long-term joint damage. All require regular blood monitoring.
Last updated 2026-07-04. This is general information, not a substitute for personalised medical advice.